Is sentinel lymph node biopsy an alternative in occult breast cancer? A case report

被引:0
作者
Lopez, Rebeca De la Iglesia [1 ]
Garcia-Novoa, Alejandra [2 ]
Conde, Carmen [1 ]
Alejandro, Alberto Bouzon [2 ]
Acea-Nebril, Benigno [2 ]
机构
[1] Complejo Hosp Univ A Coruna, Serv Ginecol, Unidad Mama, La Coruna, Spain
[2] Complejo Hosp Univ A Coruna, Serv Cirugia Gen, Unidad Mama, La Coruna, Spain
来源
REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA | 2024年 / 37卷 / 02期
关键词
Directed axillary; dissection; Case-report; Occult carcinoma; Breast; Sentinel node lymph biopsy; Axilla; RADIOTHERAPY; CARCINOMA; SURGERY; AXILLA;
D O I
10.1016/j.senol.2024.100575
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Occult breast carcinoma is a very rare entity that is defined as the presence of axillary disease without detectable tumor in the breast. When searching for the origin of a tumor, the use of bimodal techniques such as PET/CT has become especially useful, but there is little evidence about the management of these tumors. Currently, the standard treatment is primary systemic therapy (PST), followed by axillary lymphadenectomy and radiotherapy of the breast and lymph node chains. In this case we present the possibility of treating this disease with a more conservative surgical approach: through directed axillary dissection in a patient with occult breast carcinoma, who debuted with the appearance of a single axillary adenopathy observed on tomography. After completing primary systemic therapy, a complete radiological response was confirmed and a directed axillary dissection was indicated, with evidence in the operating room of a coincidence between the sentinel lymph node and the lymph node initially biopsied. After completing the treatment with radiotherapy of the breast and lymph node chains and anti-Her2 therapy, the patient is disease-free. It seems that an axillary treatment similar to that of locally advanced breast cancer can be considered, so in limited axillary disease (N1) targeted axillary dissection associated with radiotherapy could be an alternative. (c) 2024 SESPM. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页数:4
相关论文
共 10 条
  • [1] Acea-Figueira E, 2023, CIR ESPAN, V101, P417, DOI [10.1016/j.ciresp.2022.05.004, 10.1016/j.cireng.2022.06.007]
  • [2] [Anonymous], 2023, Breast Cancer. Version 4
  • [3] Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy
    Cohen, Brianna L.
    Collier, Amber L.
    Kelly, Kristin N.
    Goel, Neha
    Kesmodel, Susan B.
    Yakoub, Danny
    Moller, Mecker
    Avisar, Eli
    Franceschi, Dido
    Macedo, Francis I.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 1830 - 1841
  • [4] Delgado-Bolton RC, 2003, J NUCL MED, V44, P1301
  • [5] Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
    Donker, Mila
    van Tienhoven, Geertjan
    Straver, Marieke E.
    Meijnen, Philip
    van de Velde, Cornelis J. H.
    Mansel, Robert E.
    Cataliotti, Luigi
    Westenberg, A. Helen
    Klinkenbijl, Jean H. G.
    Orzalesi, Lorenzo
    Bouma, Willem H.
    van der Mijle, Huub C. J.
    Nieuwenhuijzen, Grard A. P.
    Veltkamp, Sanne C.
    Slaets, Leen
    Duez, Nicole J.
    de Graaf, Peter W.
    van Dalen, Thijs
    Marinelli, Andreas
    Rijna, Herman
    Snoj, Marko
    Bundred, Nigel J.
    Merkus, Jos W. S.
    Belkacemi, Yazid
    Petignat, Patrick
    Schinagl, Dominic A. X.
    Coens, Corneel
    Messina, Carlo G. M.
    Bogaerts, Jan
    Rutgers, Emiel J. T.
    [J]. LANCET ONCOLOGY, 2014, 15 (12) : 1303 - 1310
  • [6] The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers
    Flores-Funes, Diego
    Aguilar-Jimenez, Jose
    Martinez-Galvez, Maria
    Jose Ibanez-Ibanez, Maria
    Carrasco-Gonzalez, Luis
    Ignacio Gil-Izquierdo, Jose
    Luis Aguayo-Albasini, Jose
    [J]. CIRUGIA ESPANOLA, 2020, 98 (09): : 510 - 515
  • [7] FDG PET/CT in carcinoma of unknown primary
    Kwee, Thomas C.
    Basu, Sandip
    Cheng, Gang
    Alavi, Abass
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (03) : 635 - 644
  • [8] Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis
    Macedo, Francisco Igor B.
    Eid, Joseph J.
    Flynn, Jeff
    Jacobs, Michael J.
    Mittal, Vijay K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (06) : 1838 - 1844
  • [9] Breast Radiotherapy for Occult Breast Cancer with Axillary Nodal Metastases - Does it Reduce the Local Recurrence Rate and Increase Overall Survival?
    Masinghe, S. P.
    Faluyi, O. O.
    Kerr, G. R.
    Kunkler, I. H.
    [J]. CLINICAL ONCOLOGY, 2011, 23 (02) : 95 - 100
  • [10] Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial
    Savolt, A.
    Peley, G.
    Polgar, C.
    Udvarhelyi, N.
    Rubovszky, G.
    Kovacs, E.
    Gyorffy, B.
    Kasler, M.
    Matrai, Z.
    [J]. EJSO, 2017, 43 (04): : 672 - 679